The Scientist

» tumor targeting

Most Recent

image: Personalized Cancer Vaccines

Personalized Cancer Vaccines

By | April 2, 2015

A dendritic cell vaccine targeting melanoma patients’ tumor-specific mutations can activate a broad range of cancer-fighting T cells. 

2 Comments

image: Targeted Brain Cancer Vaccine

Targeted Brain Cancer Vaccine

By | June 25, 2014

Mouse study demonstrates the ability of a cancer vaccine targeted against a specific oncogenic mutation to elicit a protective anti-tumor immune response. 

1 Comment

image: Opinion: Overcoming Cancer’s Complexities

Opinion: Overcoming Cancer’s Complexities

By , , and | April 11, 2014

Considering “targeted therapeutics” in the face of intra-patient heterogeneity. 

2 Comments

image: Radiation Therapy Damages Neurons

Radiation Therapy Damages Neurons

By | July 16, 2013

Cranial irradiation, a common brain cancer treatment, disrupts neural morphology in mice in ways that resemble damage caused by neurodegenerative conditions.

2 Comments

image: Antibody-Drug Combo Approved

Antibody-Drug Combo Approved

By | February 25, 2013

The FDA approves an antibody-drug conjugate that effectively treats a certain type of advanced breast cancer with fewer side effects than previous drugs.

0 Comments

image: Communication helps target tumors

Communication helps target tumors

By | June 20, 2011

Proteins and nanoparticles that talk in order to more efficiently locate and treat tumors could reduce collateral damage to healthy tissues.

18 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham